Use este identificador para citar ou linkar para este item: http://sgc.anlis.gob.ar/handle/123456789/2490
Título: International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease
Autor(es): Gladstone, R A 
Siira, L 
Brynildsrud, O B 
Vestrheim, D F 
Turner, P 
Clarke, S C 
Srifuengfung, S 
Ford, R 
Lehmann, D 
Egorova, E 
Voropaeva, E 
Haraldsson, G 
Kristinsson, K G 
McGee, L 
Breiman, R F 
Bentley, Stephen D 
Sheppard, C L 
Fry, N K 
Corander, J 
Toropainen, M 
Steens, A 
Palavras-chave: Epidemiología Molecular;Brotes de Enfermedades;PCVs;PPV23;Neumonía Neumocócica;ST801;Serogrupo 4;Streptococcus pneumoniae;Secuenciación Completa del Genoma
Data do documento: 11-Fev-2022
Jornal: Vaccine 
Resumo: 
Pneumococcal disease outbreaks of vaccine preventable serotype 4 sequence type (ST)801 in shipyards have been reported in several countries. We aimed to use genomics to establish any international links between them.
Descrição: 
Fil: Gladstone, R A. Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Parasites and Microbes, Wellcome Sanger Institute; United Kingdom

Fil: Siira, L. Department of Health Security, Finnish Institute for Health and Welfare (THL); Finland

Fil: Brynildsrud, O B. Division of Infection Control and Environmental Health, Norwegian Institute of Public Health; Norway

Fil: Vestrheim, D F. Division of Infection Control and Environmental Health, Norwegian Institute of Public Health; Norway

Fil: Turner, P. Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Cambodia Oxford Medical Research Unit, Angkor Hospital for Children; Cambodia

Fil: Clarke, S C. Faculty of Medicine and Institute of Life Sciences, University of Southampton, UK; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Trust, Southampton, United Kingdom; Global Health Research Institute, University of Southampton, Southampton, United Kingdom; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia; Centre for Translational Research, IMU Institute for Research, Development and Innovation (IRDI); Malaysia

Fil: Srifuengfung, S. Faculty of Pharmacy, Siam University; Thailand

Fil: Ford, R. Papua New Guinea Institute of Medical Research, PO Box 60; Papua New Guinea

Fil: Lehmann, D. Telethon Kids Institute, the University of Western Australia; Australia

Fil: Egorova, E. G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology; Russia

Fil: Voropaeva, E. G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology; Russia

Fil: Haraldsson, G. Department of Clinical Microbiology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland and Faculty of Medicine, University of Iceland; Iceland

Fil: Kristinsson, K G. Department of Clinical Microbiology, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland and Faculty of Medicine, University of Iceland; Iceland

Fil: McGee, L. Centers for Disease Control and Prevention; United States

Fil: Breiman, R F. Emory Global Health Institute; United States

Fil: Bentley, S D. Parasites and Microbes, Wellcome Sanger Institute; United Kingdom

Fil: Sheppard, C L. Vaccine Preventable Bacteria Section, Public Health England - National Infection Service; United Kingdom

Fil: Fry, N K. Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, London, United Kingdom; Immunisation and Countermeasures Division, Public Health England - National Infection Service; United Kingdom

Fil: Corander, J. Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway; Parasites and Microbes, Wellcome Sanger Institute; United Kingdom

Fil: Toropainen, M. Department of Health Security, Finnish Institute for Health and Welfare (THL); Finland

Fil: Steens, A. Division of Infection Control and Environmental Health, Norwegian Institute of Public Health; Norway
URI: http://sgc.anlis.gob.ar/handle/123456789/2490
DOI: 10.1016/j.vaccine.2021.10.046
Aparece nas Coleções:Artículos

Arquivos neste item:
Arquivo Descrição TamanhoFormato
main.pdf509.59 kBAdobe PDFVer/Aberto
Mostrar registro completo do item

Visualização de página

21
Checado em 27/07/2024

Download(s)

2
Checado em 27/07/2024

Google ScholarTM

Checar

Altmetric

Altmetric


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.